REG - Velocys PLC - Result of general meeting and total voting rights

VelocysAnnouncement

08/08/2018 12:30

RNS Number : 2218X
Velocys PLC
08 August 2018
 


News release
Velocys plc
("Velocys" or "the Company")
8 August 2018
 
Result of general meeting and total voting rights
 
Velocys plc (VLS.L), the renewable fuels company, is pleased to announce that, in connection with the £6 million fundraising announced by the Company on 23 July 2018 (the "Placing"), all resolutions put to shareholders at the General Meeting today were duly passed.
 
Application has been made for the Second Tranche Placing Shares (being 30,000,000 Placing Shares) to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur on 9 August 2018. Following Admission, the Company will have 390,322,765 shares in issue.
 
The Company does not currently hold any shares in treasury. Accordingly, the above figure of 390,322,765 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.
 
- Ends -
 
For further information, please contact:




Velocys
David Pummell, CEO
 


+44 1235 838 621
 




Numis Securities (Nomad and joint broker)
Alex Ham
Stuart Skinner
Jamie Lillywhite
Tom Ballard
 


+44 20 7260 1000




Canaccord Genuity (Joint broker)
Henry Fitzgerald-O'Connor
Ben Griffiths
 


+44 20 7523 8000
 




Camarco (Financial communications & PR)
Billy Clegg
Georgia Edmonds
Tom Huddart
 


+44 20 3757 4983
 




Scoville Public Relations (US public relations)
John Williams
 
 
 


+1 206 625 0075#1
 




www.velocys.com 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCPPMBTMBTMBBP